BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17219614)

  • 1. Anti-HIV agents. How long will a first regimen last?
    TreatmentUpdate; 2003; 15(5):1-2. PubMed ID: 17219614
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Alternating regimens look promising.
    TreatmentUpdate; 2003; 15(5):2-3. PubMed ID: 17216855
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HIV agents. Is FOTO a treatment interruption that works?
    TreatmentUpdate; 2005; 17(5):10-1. PubMed ID: 17219661
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 5. I will urge caution.
    Garcia B
    WORLD; 2000 Jan; (105):5. PubMed ID: 11851144
    [No Abstract]   [Full Text] [Related]  

  • 6. Who gets treatment and...side effects.
    TreatmentUpdate; 2002 Dec; 14(9):2-3. PubMed ID: 12593382
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral rounds. First holiday was a disaster: should she take another?
    Estanislao L; Simpson D; Cohen CJ
    AIDS Clin Care; 2004 May; 16(5):40-1. PubMed ID: 15199864
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV agents. Drug holidays.
    TreatmentUpdate; 2003; 15(5):3-4. PubMed ID: 17216856
    [No Abstract]   [Full Text] [Related]  

  • 9. When to start treatment.
    Surviv News (Atlanta Ga); 2001 May; ():1, 8. PubMed ID: 11682725
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating HIV: when to start, who should treat, and still missing many.
    Laurence J
    AIDS Read; 2008 Jun; 18(6):285-6. PubMed ID: 18623889
    [No Abstract]   [Full Text] [Related]  

  • 11. Structured treatment interruption and immune reconstitution.
    Berger DS
    Posit Aware; 2002; 13(2):36-7. PubMed ID: 12004832
    [No Abstract]   [Full Text] [Related]  

  • 12. When to start treatment.
    Proj Inf Perspect; 2001 Mar; (32):1-4. PubMed ID: 11682771
    [No Abstract]   [Full Text] [Related]  

  • 13. New developments in STIs and SIT.
    Proj Inf Perspect; 2000 Oct; (31):5. PubMed ID: 12171020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruptions may be beneficial.
    AIDS Patient Care STDS; 2002 Oct; 16(10):512. PubMed ID: 12442736
    [No Abstract]   [Full Text] [Related]  

  • 15. In for the long haul: debate paves way for long-term trials.
    Bass E
    Res Initiat Treat Action; 2001; 7(1):5-7. PubMed ID: 11548386
    [No Abstract]   [Full Text] [Related]  

  • 16. A guide for understanding the guidelines.
    Sharp M
    Posit Aware; 2004; 15(1):43-5. PubMed ID: 14989197
    [No Abstract]   [Full Text] [Related]  

  • 17. The current status of antiretroviral therapy in Africa.
    Bray DH
    J HIV Ther; 2006 Mar; 11(1):7-10. PubMed ID: 16706249
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage strategies and STI at the 10th Annual Retrovirus Conference.
    Huff B
    GMHC Treat Issues; 2003; 17(1-2):8-10. PubMed ID: 12691029
    [No Abstract]   [Full Text] [Related]  

  • 19. When to start antiretroviral therapy? NA-ACCORD stimulates the debate.
    Gallant JE
    AIDS Read; 2009 Feb; 19(2):49-50, 61. PubMed ID: 19271328
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV agents. A warning about high viral loads.
    TreatmentUpdate; 2003; 15(7):1-2. PubMed ID: 17216865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.